Cervical Cancer Outcomes in Women With HIV in the Age of Antiretroviral Therapy
This cross-sectional study investigates the outcomes for women living with HIV and cervical cancer in the US after the emergence of antiretroviral therapy.
Authors
- Anna E. Coghill (ORCID: https://orcid.org/0000-0001-7142-7499)
- Kevin Albuquerque (ORCID: https://orcid.org/0000-0003-4067-6518)
- Rehema Thomas (ORCID: https://orcid.org/0000-0002-1230-9094)
- Michelle Ludwig (ORCID: https://orcid.org/0000-0001-8860-7269)
- Dana M. Roque (ORCID: https://orcid.org/0000-0002-7098-6376)
- Elizabeth Y. Chiao (ORCID: https://orcid.org/0000-0001-5752-2916)
- Austin Huang (ORCID: https://orcid.org/0000-0002-0725-0809)
- Kristina Bowles (ORCID: https://orcid.org/0000-0002-1091-0978)
- Alison K. Yoder (ORCID: https://orcid.org/0000-0002-2606-3814)
- Christina H. Son (ORCID: https://orcid.org/0000-0002-2089-9004)
- Lilie L. Lin
- Kimberly Levinson (ORCID: https://orcid.org/0000-0002-6457-9635)
- Anushka S Mandalapu
Institutions
- Gynecologic Oncology Group (US)
- The University of Texas MD Anderson Cancer Center (US)
- Johns Hopkins University (US)
- Baylor College of Medicine (US)
- Johns Hopkins Medicine (US)
- Moffitt Cancer Center (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
- University of Maryland, College Park (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.27389
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- AstraZeneca
- Varian Medical Systems
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
- National Cancer Institute